O
DCPH

OrbiMed’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

OrbiMed’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,183,143
Closed -$74.2M – 178
2021
Q3 		$74.2M Sell
2,183,143
-1,114,158
-34% -$35.6M 0.82% 38
2021
Q2 		$121M Buy
3,297,301
+1,916,401
+139% +$74.2M 1.22% 26
2021
Q1 		$61.9M Buy
1,380,900
+255,200
+23% +$11.9M 0.58% 49
2020
Q4 		$64.2M Hold
1,125,700
– – 0.56% 51
2020
Q3 		$57.7M Hold
1,125,700
– – 0.73% 39
2020
Q2 		$67.2M Sell
1,125,700
-31,900
-3% -$1.71M 0.95% 32
2020
Q1 		$47.7M Sell
1,157,600
-356,571
-24% -$19.8M 0.8% 39
2019
Q4 		$94.2M Sell
1,514,171
-946,400
-38% -$45M 1.35% 28
2019
Q3 		$83.5M Sell
2,460,571
-1,157,600
-32% -$34.3M 1.58% 21
2019
Q2 		$81.6M Hold
3,618,171
– – 1.26% 25
2019
Q1 		$84M Buy
3,618,171
+1,175,971
+48% +$30.8M 1.3% 22
2018
Q4 		$51.3M Buy
2,442,200
+488,700
+25% +$12M 0.95% 35
2018
Q3 		$75.6M Sell
1,953,500
-52,200
-3% -$1.93M 0.91% 31
2018
Q2 		$78.9M Buy
2,005,700
+472,800
+31% +$13.9M 0.94% 36
2018
Q1 		$30.7M Buy
1,532,900
+356,830
+30% +$9.04M 0.38% 67
2017
Q4 		$26.7M Buy
1,176,070
+781,800
+198% +$15.3M 0.34% 70
2017
Q3 		$7.49M Buy
+394,270
New +$7.22M 0.07% 111

Other funds holding DCPH

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

OrbiMed's DCPH Position: Q4 2021 in Review

OrbiMed sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 2,183,143 shares — an estimated $74.2M sold.

OrbiMed first reported a position in DCPH in Q3 2017 and held it in 17 quarters. The position peaked at $121M in Q2 2021. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

  • OrbiMed reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • OrbiMed sold 2,183,143 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $74.2M.
  • OrbiMed first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 17 quarters.
  • OrbiMed's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $121M in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on OrbiMed's 13F filing for Q4 2021, filed 14 Feb 2022.